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Abstract 
The decapeptide gonadotropin-releasing hormone (GnRH) is degraded by the 20 S multicatalytic proteinase complex (proteasome EC 3.4.99.46), 
purified from ovarian granulosa cells, at the Tyr5431y 6 bond and to a lesser extent at the Gly6-Leu 7bond, when incubated for 2 h at 37°C. Further 
cleavage, at Trp3-Ser 4and Serd-Tyr 5bonds of the neurohormone occurs only subsequently to the appearance of the initial N-terminal degradation 
products, (1-5)GnRH and (1-6)GnRH. Our results uggest that the sequential degradation of GnRH can serve as an important mechanism for the 
rapid termination of its biological activity in target ceils. 
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1. Introduction 
The proteasome, a non-lysosomal multicatalytic pro- 
teinase complex, plays a key role in the selective cellular 
degradation of defective, poorly folded or short-lived 
regulatory proteins [1-3]. Moreover, proteasomes are 
implicated in the provision of antigenic peptides which 
are associated with the major histocompatibility com- 
plex class of molecules [4--6]. The barrel-shaped complex 
has a molecular mass of 700 kDa [7,8] and contains up 
to 14 different subunits, all encoded by members of one 
gene family [9]. 
Gonadotropin-releasing hormone, a decapeptide 
(pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2; 
GnRH), is a primary regulator of the reproductive cycle. 
This neurohormone is synthesized in hypothalamic neu- 
rosecretory cells, released in a pulsatile pattern into the 
hypothalamo-pituitary portal system and triggers the 
synthesis and secretion of the gonadotropic hormones 
luteinizing hormone (LH) and fillicle stimulating 
hormone (FSH) from the anterior pituitary [10-14]. It 
has also been found that GnRH can act directly on the 
rat gonads to inhibit steroidogenesis in males and ovula- 
tion in females. Direct effect of GnRH on cultured rat 
and human granulosa cells via specific receptors located 
at the cell membrane have been demonstrated [15-20]. In 
cells obtained from rat preantral follicle, GnRH agonist 
block gonadotropin duced formation of LH receptors 
and progesterone production [18,20]. In contrast, GnRH 
agonist significantly stimulate progesterone production 
in granulosa cells obtained from preovulatory follicles 
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[21]. Thus, GnRH can affect directly maturation and 
luteinization of granulosa cells. Since GnRH can initiate 
the cascade of the signal transduction pathway, involv- 
ing the activation of phospholipase D, which leads to the 
hydrolysis of phospholipids [21,22], termination of such 
a signal also seems to be essential for cell viability. More- 
over, since GnRH acts as a neurotransmitter or a neuro- 
modulator [23,24] and since the pulsatile pattern of secre- 
tion of GnRH is crucial for the proper esponsiveness of 
the pituitary gland [25], it is clear that mechanisms of 
efficient and rapid degradation of GnRH are needed. 
GnRH, by virtue of the presence of an N-terminal 
pyroglutamate residue and a C-terminal amide bond, is 
resistant o degradation by most exopeptidases. The 
enzymatic degradation of GnRH must therefore be con- 
trolled by endopeptidases [26,27]. Proteasomes can 
degrade synthetic oligopeptides but their role in the 
degradation of natural existing bioactive peptides like 
neurotransmitters and hormones is still unclear. Inter- 
nalization of the GnRH-receptor complex in target cells 
following its binding to the receptors was previously 
demonstrated [28]. Therefore, degradation of internal- 
ized cytosolic GnRH could be part of the GnRH inacti- 
vation mechanism. As we have previously demonstrated 
that GnRH degrading activity is present in the rat ovary 
[29] and since highly purified proteasomes were recently 
isolated from immortalized ovarian granulosa cells [30], 
the possible involvement ofthese nzymes in termination 
of the action of GnRH by proteolytic activity of pro- 
teasomes was examined. In the present communication 
we demonstrate, for the first time, that granulosa cell 
proteasome in microgram quantities can efficiently de- 
grade physiological concentrations of GnRH (nM). 
Moreover, the progressive degradation of GnRH to 
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small fragments (1-6), (1-5), 1-4) and (1 -3 )GnRH pro- 
vides new insights into the mechanism of action of the 
proteasome. 
2. Materials and methods 
2.1. Isolation of proteasomes from POGRS1 granulosa cell line 
Proteasomes were isolated from cultured POGRS1 ceils as described 
recently [31]. Briefly, supernatant (13,500 x g) of cell lysates were chro- 
matograpbed on DEAE Sephacel ion-exchange column followed by 
chromatography onSephacryl HR-S-400 gel filtration column (Phar- 
macia, Sollentuna, Sweden). Fractions containing the main activity, as 
indicated by chymotripsin-like proteolytic activity (with Suc-Ala-Phe-7 
aminomethyl coumarin) [30], were subjected to an additional cycle of 
ion-exchange chromatography using Mono Q fast protein liquid 
chromatography (FPLC) (Pharmacia). All proteolyticaily active frac- 
tions were examined by SDS-PAGE. The fractions containing the pro- 
teasomes a the major protein were pooled, concentrated and chroma- 
tographed on a Superose-6 gel filtration column (Pharmacia). The pu- 
rity of the isolated proteasomes was verified both by gel electrophoresis 
and electron microscopy of negatively stained proteasomes. 
2.2. Synthesis of GnRH marker f agments 
The 1-3 and 14 fragments ofCmRH were synthesized and used as 
markers for identification ofGnRH degradation products. The frag- 
ments were synthesized using the solid phase method [31] on a manual 
solid phase peptide synthesizer. Optimized protection of side chain 
functional groups minimized their participation i  undesirable side 
reaction bonds. 
2.3. Assay for GnRtt degrading activity in purified proteasomes 
The assay for degradation was performed as follows: Aliquots of the 
proteasomes containing 15 pg protein (determined by the method of 
Bradford [32]) were incubated with 1.2 pmol of [3H]GnRH labeled at 
the N-terminal residue (NEN-DuPont, Regensdorf, Switzerland). The 
final volume of the reaction was 50 pl of 20 mM Tris-HC1 buffer pH 
7.4 containing 1mM EDTA. The reaction was carried out for 0, 2, 4, 
8, 16, 24 and 48 h in a shaking water bath at 37°C, and was terminated 
by heating the samples in a boiling water bath for 5 rain. Preheated 
proteasomes (5 rain in a boiling water bath) incubated with [3H]GnRH 
were used for control reactions. 
2.4. Separation and identification fGnRH degradation products by 
TLC (RP-18) 
The procedure was basically carded out according to the method 
developed by Leibovitz et al. [33]. Briefly, the GnRH degradation 
reaction mixtures were concentrated by Speed-Vac entrifugation 
(3,000 rpm; 0.5 ram) and the pellets were resuspended in 25/zl of 
methanol. Samples of the solutions (20 pl) were resolved on reversed- 
phase precoated glass plates (5 x 10 cm TLC RP-18) employing, as a 
solvent, 20% acetonitrile inwater (v/v) containing 0.1% trifluoroacetic 
acid (TFA). This was followed by a second run using as a solvent a 
solution of 25% acetonitrile inwater (v/v) containing 0.1% TFA. The 
TLC plates were prepared for autoradiography b spraying with 
EN3HANCE and then exposed for 24 h at -70°C. Identification of 
intact labeled GnRH and labeled egradation products were accompa- 
nied by co-chromatography with synthetic GnRH, and its synthetic 
N-terminal fragments (1-2, 1-3, 1--4, 1-5, 1-6 and 1-7CmRH). The 
mobility of these synthetic markers was determined by spraying the 
plates with Pauly and Ehrlich's reagents [34]. The bands corresponding 
to the labeled intact GnRH and labeled egradation products were 
tentatively identified by their Rf values relative to the markers. 
3. Results and discussion 
When [3H]GnRH was incubated with highly purified 
granulosa cell proteasomes at 37°C for different periods 
of time, progressive degradation of the decapeptide neu- 
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rohormone was evident (Fig. 1). After two hours of reac- 
tion, the major detectable labeled product, by thin layer 
chromatography, was the N-terminal  pentapeptide 
pGlu-His-Trp-Ser-Tyr, (1-5)GnRH.  It was accompa- 
nied by smaller amounts of the N-terminal  hexapeptide 
pGlu-His-Trp-Ser-Tyr-Gly, (1-6)GnRH.  After 4 h of in- 
cubation, the amounts of (1-5) and (1 -6 )GnRH signifi- 
cantly increased and at 8 h of incubation a third degra- 
dation product, the N-terminal  pGlu-His-Trp, 
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Fig. 1. The degradation pattern of CmRH as a function of time. Purified 
proteasomes (15/Jg protein) were incubated for different time intervals 
(0, 2, 4, 8, 24 h) at 37°C with 1.2 pmol [3H]GnRH. The incubation was 
terminated and the degradation products were separated as described 
in section 2. (a) A representative (out of three xperiments) radiochro- 
matograph TLC separation of the labeled GnRH and the N-terminal 
degradation products that were generated, is shown. The arrows indi- 
cate the position of the different synthetic GnRH fragment markers. 
(b) The percentage of GnRH remaining; and (c) the appearance of the 
degradation products, as quantitated by density measurements of the 
labeled GnRH and of the labeled egradation products on the TLC 
autoradiogram (Computing Densitometer, Model 30, Molecular Dy- 
namics). 
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Fig. 2. Identification fGnRH fragments generated following degradation fthe neurohormone by purified proteasomes. (a) TLC separation. 
Aliquots of purified proteasomes isolated from the POGS5 cell ine (15 gg protein) were incubated with 1.2 pmol [3H]GnRH for 48 h at 37°C. The 
incubation was terminated byheating the samples and the degradation products were separated byreversed phase RP-18 TLC, as described in section 
2. The arrows indicate the positions of synthetic markers. This experiment was repeated three times. (b) HPLC separation. Following the degradation 
reaction, GnRH products were fractionated ona RP-CIs HPLC column and co-eluted with synthetic GnRH markers using a 60 min linear gradient 
of 10--60% acetonitrile n 0.1% TFA at a flow rate of 1 ml/min. The absorbance at 280 nm was monitored. The radioactivity of each fraction (0.5 
ml) was determined in a liquid scintillation spectrometer. The degradation products were identified by comparing their etention time to that of 
synthetic GnRH markers. The arrows indicate the retention time of the different markers. 
(1-3)GnRH, was visible. Following 16 h of incubation, 
a pronounced rise in the quantity of (1-3)GnRH was 
evident and a fourth degradation product, the N-termi- 
nal pGlu-His-Trp-Ser, (1-4)GnRH, appeared. At 24 h of 
incubation there was a further increase in the formation 
of (1-3)GnRH product, concomitant with a decrease of 
the (1-5)GnRH degradation product (Fig. la). An in- 
verse relationship between the appearance ofGnRH deg- 
radation products and that of the intact GnRH was ob- 
served, namely the latter decreased sharply whereas the 
former increased as a function of time (Fig. l b and c). 
To confirm the identity of the degradation products ep- 
arated by the TLC method and visualized by autoradi- 
ography, we used high-pressure liquid chromatography 
(HPLC), which could demonstrate co-elution of the ap- 
propriate synthetic GnRH markers with the degradation 
products generated by the proteasomes (Fig. 2). The 
ratio between the different products fractionated by 
HPLC was identical to that quantified by the densiomet- 
ric analysis of TLC autoradiography. 
The results obtained indicate that the granulosa cell 
proteasomes can cleave peptide bonds between amino 
acids, Trp3-Ser 4, Ser4-Tyr 5, TyrS-Gly 6 and Gly6-Leu 7
(Fig. 3). While the enzymatic degradation of GnRH by 
a multicatalytic proteinase complex from pituitary origin 
was briefly referred [35], this is the first detailed report 
on the proteolysis of the neurohormone GnRH by 20 S 
proteasomes. The kinetics of the generation of GnRH 
products suggests that the decapeptide is initially de- 
graded to yield a pentapeptide and a hexapeptide which 
then become available to other catalytic sites within the 
granulosa proteasome complex (Fig. 3). Possibly the size 
of the polypeptide substrate is critical for its accommo- 
dation and cleavage at the different catalytic sites which 
are localized on distinct subunits of the 20 S pro- 
teasomes. Thus, the Trp3-Ser 4peptide bond may become 
available to the appropriate catalytic site(s) only after a 
smaller substrate (i.e. (1-5) or (1-6)GnRH) is generated. 
Indeed, the amount of these fragments was further in- 
creased after 24 h of degradation, although GnRH was 
already not available after 16 h of reaction (Fig. 1 a and 
b). This is in line with the proposition that proteasomes 
possess a 'ruler' which determines the lengths of the deg- 
radation products [36]. This could explain the preferen- 
tial appearance of the N-terminal (1-5) or (1-6)GnRH 
as an early event of GnRH proteolysis and the delayed 
appearance of the N-terminal (1-3) and (1-4)GnRH. 
The data are also in line with the suggestion that human 
erythrocyte proteasomes can degrade polypeptides pro- 
gressively by channeling intermediates from one catalytic 
site to another as was concluded from experiments using 
oxidized insulin B chain as a substrate [37]. 
Proteasomes from pituitary [35] and from ovarian 
GnRH 
pGlu-Hi s-Trp-Ser-Tyr-:Gly~Leu-Arg-Pro-Gly-NH2 
(i-5)GnRH/ t ~-6)GnRH 
pGlu-His-Trp 
pGlu-His-Trp-Ser~Tyr-Gly 
~ 1-4)GnRH 
pGlu-His-Trp-Ser 
Fig. 3. The proposed pathways of GnRH degradation by purified 
proteasomes. 
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granulosa cells [30] were recently isolated and their pro- 
teolytic activity on synthetic polypeptides was examined. 
Both the pituitary gonadotropes and rat granulosa cells 
express receptors to GnRH, which, upon binding of the 
peptide regulate pituitary-gonadal function. It was al- 
ready demonstrated that proteases of the anterior pitui- 
tary can efficiently degrade GnRH [27]. Since GnRH is 
internalized subsequent to the interaction with its spe- 
cific receptor located on the cell membrane [28], it is 
tempting to suggest hat following cell entry the 20 S 
proteasome can degrade GnRH and thus terminate its 
activity. It was clearly demonstrated that prolonged ac- 
tion of GnRH leads to desensitization of the pituitary 
gland, resulting in severe interference with gonadal func- 
tion [15]. Continuous administration of high concentra- 
tions of GnRH to female rats has been recently shown 
to lead to programmed cell death in ovarian follicles [38]. 
Since proteasomes were found in all mammalian cells 
examined so far, it is possible that the 20 S proteasomes 
can serve as an efficient, general cellular tool for clear- 
ance of small natural and other bioactive peptides uch 
as GnRH, neurotensin, etc., after their interaction with 
their specific receptor, and subsequent internalization. 
Undesirable, often pathological, consequences of over- 
activation by these molecules can thus be controlled. 
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